Acceptance of vaccinations in pandemic outbreaks: A discrete choice experiment

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Determann, Domino ^a,b   Korfage, Ida J ^a   Lambooij, Mattijs S ^b   Bliemer, Michiel ^c   Richardus, Jan Hendrik ^a,d   Steyerberg, Ewout W ^a   De Bekker Grob, Esther W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Rotterdam Rijnmond Public Health Service   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATTENTION; CLINICAL EFFECTIVENESS; COMMUNICABLE DISEASE; COST EFFECTIVENESS ANALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MIDDLE AGED; PANDEMIC; POPULATION RESEARCH; PREDICTION; SAFETY; SOCIAL ACCEPTANCE; SOCIAL MEDIA; VACCINATION; YOUNG ADULT; ADOLESCENT; DECISION MAKING; ECONOMICS; HEALTH CARE COST; IMMUNOLOGY; NETHERLANDS; PANDEMICS; PREVENTIVE HEALTH SERVICE; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; UTILIZATION;

ADOLESCENT; ADULT; AGED; CHOICE BEHAVIOR; COMMUNICABLE DISEASES; DISEASE SUSCEPTIBILITY; FEMALE; HEALTH EXPENDITURES; HUMANS; IMMUNIZATION PROGRAMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NETHERLANDS; PANDEMICS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; VACCINATION;

EID: 84904818185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102505     Document Type: Article

References (45)

1. Viboud C, Miller M, Olson D, Osterholm M, Simonsen L (2010) Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons. PLoS Curr 2: RRN1153.
2. Nguyen-Van-Tam JS, Hampson AW (2003) The epidemiology and clinical impact of pandemic influenza. Vaccine 21: 1762-1768. (Pubitemid 36398370)
3. Murray CJ, Lopez AD, Chin B, Feehan D, Hill KH (2006) Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 368: 2211-2218. (Pubitemid 44959013)
4. Ferguson NM, Cummings DA, Cauchemez S, Fraser C, Riley S, et al. (2005) Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437: 209-214. (Pubitemid 41294478)
5. Longini IM Jr, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, et al. (2005) Containing pandemic influenza at the source. Science 309: 1083-1087. (Pubitemid 41134467)
6. Stern EK, Young S, Amlôt R, Blake A, Dacey G, et al. (2010) Assessment Report on EU-wide Pandemic Vaccine Strategies. European Commission.
7. Bish A, Yardley L, Nicoll A, Michie S (2011) Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine 29: 6472-6484.
8. Nguyen T, Henningsen KH, Brehaut JC, Hoe E, Wilson K (2011) Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public. Infect Drug Resist 4: 197-207.
9. Mereckiene J, Cotter S, Weber JT, Nicoll A, D'Ancona F, et al. (2012) Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. Euro Surveill 17.
10. de Bekker-Grob EW, Ryan M, Gerard K (2012) Discrete choice experiments in health economics: a review of the literature. Health Econ 21: 145-172.
11. Ryan M, Gerard K (2003) Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy 2: 55-64.
12. de Bekker-Grob EW, Hofman R, Donkers B, van Ballegooijen M, Helmerhorst TJ, et al. (2010) Girls' preferences for HPV vaccination: a discrete choice experiment. Vaccine 28: 6692-6697.
13. Flood EM, Ryan KJ, Rousculp MD, Beusterien KM, Divino VM, et al. (2011) Parent preferences for pediatric influenza vaccine attributes. Clin Pediatr (Phila) 50: 338-347.
14. Ryan M (2004) Discrete choice experiments in health care. BMJ 328: 360-361.
15. Hensher DA, Rose JM, Greene WH (2005) Applied choice analysis: a primer. Cambridge: Cambridge University Press.
16. Lancaster KJ (1966) A new approach to consumer theory. J Polit Econ 74: 132-157.
17. McFadden D (1974) Conditional logit analysis of qualitative choice behavior. In: Zarembka P, editor. Frontiers of Economics. London: Academic. 105-142.
18. Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, et al. (2011) Conjoint analysis applications in health - a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health 14: 403-413.
19. Lancsar E, Louviere J (2008) Conducting discrete choice experiments to inform healthcare decision making: a user's guide. Pharmacoeconomics 26: 661-677. (Pubitemid 351989058)
20. Coast J, Al-Janabi H, Sutton EJ, Horrocks SA, Vosper AJ, et al. (2012) Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. Health Econ 21: 730-741.
21. Janz NK, Becker MH (1984) The Health Belief Model: a decade later. Health Educ Q 11: 1-47.
22. Rogers RW (1975) A protection motivation theory of fear appeals and attitude change. Journal of Psychology: Interdisciplinary and Applied 91: 93-114.
23. Coe AB, Gatewood SB, Moczygemba LR, Goode JV, Beckner JO (2012) The use of the health belief model to assess predictors of intent to receive the novel (2009) H1N1 influenza vaccine. Inov Pharm 3: 1-11.
24. Teitler-Regev S, Shahrabani S, Benzion U (2011) Factors Affecting Intention among Students to Be Vaccinated against A/H1N1 Influenza: A Health Belief Model Approach. Adv Prev Med 2011: 353207.
25. Reed Johnson F, Lancsar E, Marshall D, Kilambi V, Muhlbacher A, et al. (2013) Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health 16: 3-13.
26. Hall J, Fiebig DG, King MT, Hossain I, Louviere JJ (2006) What influences participation in genetic carrier testing? Results from a discrete choice experiment. J Health Econ 25: 520-537.
27. Peters E, Vastfjall D, Slovic P, Mertz CK, Mazzocco K, et al. (2006) Numeracy and decision making. Psychol Sci 17: 407-413. (Pubitemid 43657915)
28. Howard K, Salkeld G (2009) Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer. Value Health 12: 354-363.
29. Tversky A, Kahneman D (1981) The framing of decisions and the psychology of choice. Science 211: 453-458. (Pubitemid 11145313)
30. Kjaer T, Bech M, Gyrd-Hansen D, Hart-Hansen K (2006) Ordering effect and price sensitivity in discrete choice experiments: need we worry? Health Econ 15: 1217-1228. (Pubitemid 44696949)
31. Hak T, Veer van der K, Jnasen H (2008) The Three-Step Test-Interview (TSTI): An observation-based method for pretesting self-completion questionnaires. Survey Research Methods 2: 143-150.
32. Marshall D, Bridges JF, Hauber B, Cameron R, Donnalley L, et al. (2010) Conjoint Analysis Applications in Health - How are Studies being Designed and Reported?: An Update on Current Practice in the Published Literature between 2005 and 2008. Patient 3: 249-256.
33. Orme BK (2006) Getting started with Conjoint Analysis: Strategies fro Product Design and Pricing Research. Madison, WI: Reserach Publishers LLC.
34. de Bekker-Grob EW, Rose JM, Donkers B, Essink-Bot ML, Bangma CH, et al. (2013) Men's preferences for prostate cancer screening: a discrete choice experiment. Br J Cancer 108: 533-541.
35. Swait J (1994) A structural equation model of latent segmentation and product choice for cross-sectional revealed preference choice data. Journal of Retailing and Consumer Services 1: 77-89.
36. Louviere JH, Hensher D, Swait JD (2000) Stated choice models: analysis and application. Cambridge: Cambridge University Press.
37. de Bekker-Grob EW, Rose JM, Bliemer MC (2013) A Closer Look at Decision and Analyst Error by Including Nonlinearities in Discrete Choice Models: Implications on Willingness-to-Pay Estimates Derived from Discrete Choice Data in Healthcare. Pharmacoeconomics 31: 1169-1183.
38. Krinsky I, Robb AL (1986) On Approximating the Statistical Properties of Elasticitities. The Review of Economics and Statistics 68: 715-719.
39. Bults M, Beaujean DJ, de Zwart O, Kok G, van Empelen P, et al. (2010) [Mexican flu: risk perception in the general public, precautionary measures and trust in information provided by the government]. Mexicaanse griep: risicoperceptie bij de bevolking, eigen maatregelen en vertrouwen in overheidsinformatie. Ned Tijdschr Geneeskd 154: A1686.
40. van der Weerd W, Timmermans DR, Beaujean DJ, Oudhoff J, van Steenbergen JE (2011) Monitoring the level of government trust, risk perception and intention of the general public to adopt protective measures during the influenza A (H1N1) pandemic in The Netherlands. BMC Public Health 11: 575.
41. Cameron MP, Newman PA, Roungprakhon S, Scarpa R (2013) The marginal willingness-to-pay for attributes of a hypothetical HIV vaccine. Vaccine 31: 3712-3717.
42. Sadique MZ, Devlin N, Edmunds WJ, Parkin D (2013) The effect of perceived risks on the demand for vaccination: results from a discrete choice experiment. PLoS One 8: e54149.
43. Henrich N, Holmes B (2009) The public's acceptance of novel vaccines during a pandemic: a focus group study and its application to influenza H1N1. Emerg Health Threats J 2: e8.
44. Freimuth V, Linnan HW, Potter P (2000) Communicating the threat of emerging infections to the public. Emerg Infect Dis 6: 337-347. (Pubitemid 30643653)
45. Kroneman M, van Essen GA, John Paget W (2006) Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine 24: 622-628. (Pubitemid 43017828)